Correction to "Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights".
ACS Chem Neurosci March 4, 2026 Nina Kastner, Núria Nadal-Gratacós, Selina Hemmer et al. correction
A correction notice clarifies that two errors in the original paper do not affect the accuracy of the results, interpretations, or conclusions. The first correction addresses a presentation issue in Table 1, confirming the data are correct. The second correction clarifies that thigmotaxis, a measure of anxiety-like behavior, was evaluated in rats given SDA or SDMA compounds. Compared to saline, only the 10 mg/kg dose of SDA significantly increased thigmotaxis, meaning the rats spent less time in the center of the arena.